Clinical Trial: A Clinical Study to Explore the Safety and Efficacy of CT1390B in Relapsed/ Refractory Acute Myeloid Leukemia

U.S., March 3 -- ClinicalTrials.gov registry received information related to the study (NCT07441980) titled 'A Clinical Study to Explore the Safety and Efficacy of CT1390B in Relapsed/ Refractory Acute Myeloid Leukemia' on Jan. 22.

Brief Summary: A Clinical Study to Investigate the Safety and Efficacy of CT1390B in Patients with Relapsed/Refractory Acute Myeloid Leukemia

Study Start Date: March 02

Study Type: INTERVENTIONAL

Condition: Relapsed/Refractory Acute Myeloid Leukemia(AML)

Intervention: DRUG: CAR-T cells chimeric antigen receptor T cells

CT1390B cells infusion

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Institute of Hematology & Blood Diseases Hospital, China

Published by HT Digital Content Services with permission f...